First Time Loading...

JD Health International Inc
HKEX:6618

Watchlist Manager
JD Health International Inc Logo
JD Health International Inc
HKEX:6618
Watchlist
Price: 30.5 HKD 1.5% Market Closed
Updated: May 5, 2024

EV/EBITDA
Enterprise Value to EBITDA

46.5
Current
35.3
Median
8.4
Industry
Higher than median
Higher than industry value

Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.

EV/EBITDA
46.5
=
Enterprise Value
44.8B
/
EBITDA
894.4m
All Countries
Close
EBITDA Growth
CN
JD Health International Inc
HKEX:6618
Average EV/EBITDA: 30.2
46.5
1 879%
US
Amazon.com Inc
NASDAQ:AMZN
19.9
116%
ZA
N
Naspers Ltd
JSE:NPN
Not Available N/A
UK
i
in Style Group PLC
LSE:ITS
Negative Multiple: -49 164.9 N/A
CN
Alibaba Group Holding Ltd
NYSE:BABA
8
44%
CN
Pinduoduo Inc
NASDAQ:PDD
19.1
199%
NL
Prosus NV
AEX:PRX
Negative Multiple: -234.1 N/A
CN
Meituan
HKEX:3690
50.8
606%
UY
MercadoLibre Inc
BMV:MELIN
33.5
127%
AR
Mercadolibre Inc
NASDAQ:MELI
33.4
127%
US
DoorDash Inc
NYSE:DASH
Negative Multiple: -614.9 N/A

EV/EBITDA Forward Multiples

Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/EBITDA
35.3
2-Years Forward
EV/EBITDA
17.6
3-Years Forward
EV/EBITDA
11.9

See Also

Discover More